3Sandberg AA, Berger CS. Review of chromosome studies in urological tumors . Ⅱ. Cytogenetics and molecular genetics of bladder cancer[J].J Urol, 1994, 151(3): 545 -560.
4Pinkel D, Straume T, GrayJW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization[J]. Proc Natl Acad Sci U S A, 1986, 83(9): 2934-2938.
5Hailing KC, King W, Sokolova IA, et al.A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma[J].J Urol, 2000, 164(5): 1768-1775.
6Zhang J, Zheng S, Gao Y, et al. A partial allelotyping of urothelial carcinoma of bladder in the Chinese[J]. Carcinogenesis, 2004, 25 (3): 343-347.
7Qin SL, Chen XJ, Xu X, et al. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization[J]. Cancer Lett, 2006, 238 (2): 230-239.
8Kruger S, Mess F, Bohle A, et al. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence m urinary bladder[J]. transitional cell carcinoma of the IntJ Oncol, 2003, 23(1): 41-48.
9Degtyar P,Neulander E,Zirkin H, et al. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional ceil carcinoma of the bladder[J]. Urology, 2004, 63 (2):398-401.
10Mhawech-Fauceglia P, Fischer G, Beck A, et al. Rafl,Aurora-A/ STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up[J]. Eur J Surg Oncol, 2006, 32(4):439-444.
